Key result
Natriuretic peptide testing, particularly BNP and NT-proBNP, is highly useful for establishing or excluding the diagnosis of heart failure in patients presenting with acute dyspnea.
Why the study?
What is the role of natriuretic peptides in the diagnosis and management of heart failure?
What is the role of natriuretic peptides in the diagnosis and management of heart failure?
Natriuretic peptides are valuable clinical markers for diagnosing heart failure in patients presenting with unexplained dyspnea.
Supports natriuretic peptide testing in acute dyspnea; leaves open optimal thresholds across comorbidities and care settings.
The natriuretic peptides are a family of related hormones that play a crucial role in cardiovascular homeostasis. They have recently emerged as potentially important clinical markers in heart failure. Recent data have suggested an important role for these markers in establishing the diagnosis of heart failure in patients with unexplained dyspnea in both acute care and ambulatory settings. Other clinical uses of the natriuretic peptides, such as screening for asymptomatic ventricular dysfunction, establishing prognosis or guiding titration of drug therapy, are under investigation but have not yet sufficiently been validated for widespread clinical use.
No takes yet. Share an insight, caveat, or question.
G. Michael Felker (2006) conducted a review in Heart failure. Natriuretic peptide testing (BNP and NT-proBNP) was evaluated. Natriuretic peptide testing, particularly BNP and NT-proBNP, is highly useful for establishing or excluding the diagnosis of heart failure in patients presenting with acute dyspnea.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: